Navigation Links
Aricept Cleared for Advanced Alzheimer's Treatment

Aricept becomes the first drug to be cleared for treatment of all stages of Alzheimer's, the FDA declared on Oct 13. It had been previously approved// for treating the initial stages of the disease. Eisai shares rose on the announcement upto 6,180 yen on the Tokyo Stock Exchange on Monday morning.

Alzheimer's is a progressive disease with no known cure, which affects brain functions of memory and thinking, leading to the patient's death after much mental deterioration. Doctors are already prescribing Aricept for the advanced stages, so the approval only gives an official status to the drug use.

The other drug being used in the US for treating the advanced stages of the disease is Namenda (Forest Laboratories).

Pfizer and Eisai entered an agreement in 1994 for promoting Aricept, which was discovered and developed by Eisai. This approval is likely to see consolidation of Pfizer's share of the Alzheimer's market. Sales of the drug have been forecast at $1.9 billion through March 2007

'"/>




Page: 1

Related medicine news :

1. Is Aricept, the Alzheimer’s Drug Safe to Use against Vascular Dementia
2. ‘Aricept’ drug gives an Alzheimer’s patient reason to smle
3. First Vaccine Designed for Africa Cleared for Testing in Humans
4. The Decks Cleared For HRT - Safe for Menopause Symptoms
5. Doctor Cleared Of Charges of Killing a baby
6. Orissa Villagers Jubilant as Girl Cleared Class X Examination
7. Patent for Seminal RNAi innovation Cleared in Australia
8. Risperdal Cleared By FDA To Treat Autistic Children
9. A Woman Dies Due to Breast Cancer After Being Cleared in the Breast Scan
10. Drug For Iron Overload Cleared
11. Advanced STD programs required
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... Beginning in 2017, Ridgecrest Herbals will be phasing ... the popular ClearLungs Extra Strength formula. To ensure that the effectiveness of Clear Lungs ... ways:, , Removal of the homeopathic element , ...
(Date:4/28/2017)... New York, NY (PRWEB) , ... April 28, ... ... Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast ... indicates recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical organization GenCure, ... at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord blood donations ... , “Women’s Hospital at Renaissance has been a collection partner for the TCBB since ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to accept that hearing aids ... doesn’t have the stigma it had when great-grandpa wore his hearing aids years ago,” ... a NALA North American Speaker Series (NASS) segment. “He probably wore an ...
Breaking Medicine News(10 mins):
(Date:4/25/2017)... April 25, 2017 Endo International plc (NASDAQ: ... 2017. Members of its senior management team will host a conference ... a.m. ET. The dial-in number to access the ... 509-7598, and the passcode is 6086379. Please dial in 10 minutes ... A replay of the call will be available from May ...
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
Breaking Medicine Technology: